Strain selection,medium development and scale-up of toyocamycin production by streptomyces chrestomyceticus |
| |
Authors: | M C Flickinger PhD M Greenstein PhD C Bremmon J Conlin |
| |
Institution: | (1) Frederick, Maryland, USA;(2) Institute for Advanced Studies in Biological Process Technology 240 Gortner Laboratories, University of Minnesota, 55108 St. Paul, Minnesota;(3) Lederle Laboratories, American Cyanamid Co., Pearle River, 10965 New York;(4) Pharmaceutical Research and Development Division, Bristol Myers Co., 2404 Pennsylvania Ave., 47721 Evansville, Indiana, USA |
| |
Abstract: | The batch productivity (Q
TM) of the production of the nucleoside antibiotic toyocamycin (TM) by Streptomyces chrestomyceticus was increased ten-fold by selection of a UV generated mutant, optimization of pH, increasing incubation temperature from 28 °C to 36 °C, and addition of soy oil. Initial high oxygen transfer rates stimulated Q
TM maxima two-fold. Antibiotic production by the mutant strain, U190, however, appeared more shear sensitive than the parent culture FCRF 341 with maximum antibiotic titer being inversely related to impellor tip velocity, T
v
. For this reason, scale-up could not be done at constant P/V or constant volumetric oxygen transfer. Instead, programming of impeller speed was evaluated in order to maintain optimal impeller tip velocity during scale-up. It was found that a low constant T
v
maintained in scale-up in geometrically similar vessels was most beneficial for duplication of optimal antibiotic productivity, Q
TM. Pilot fermentations (120 dm3 scale) were used to determine coefficients of Q
TM variation from oxygen uptake rate (OUR) and total CO2 evolution data for monitoring of Q
TM variation during scale-up to the 12,000 dm3 scale. This technique allowed for on-line prediction of antibiotic titer and Q
TM from fermentor exhaust gas data.List of Symbols
A
scale constant
-
B
shape constant
-
C
location of maximum constant
-
D m
impeller diameter (m)
-
H m
liquid height (m)
-
OTR MmolO2·(dm3)–1min–1
oxygen transfer rate
-
OUR MmolO2·(dm3)–1min–1
oxygen uptake rate
-
PCV cm3
packed cell volume
-
P/V watts/dm3
volumetric power consumption
-
Q 1 · min–1 corrected to standard conditions of temperature, pressure
aeration rate
-
Q
TM g/(cm3 · h) or kg/(m3 · h)
antibiotic productivity
-
T m
tank diameter
-
T
mix s
mixing time
-
T
v cm · s–1
impeller tip velocity
-
TM g/cm3
Toyocamycin concentration
-
TNP
Tricyclic nucleoside phosphate |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|